Answers are grounded in this paper and cite their sources.
Rapid eye movement sleep behavior disorder (RBD) marks a clinically important Parkinson disease (PD) phenotype, but subgroup-specific biochemical findings may be detectable when regional-volume contrasts are small. We performed a quantitative secondary analysis of published group summaries from 26 patients with questionnaire-defined probable RBD, 46 patients without probable RBD, and 48 controls. Among four anatomical regions selected in the primary cohort, the largest combined energetic-positive and membrane-negative pattern was observed post hoc in the right basal ganglia. Relative to controls, alpha-ATP/Pi and PCr/Pi were 39.0% and 27.7% higher (p = 0.003 and 0.001); PE/tATP was 12.5% lower than in PD-noRBD (p = 0.003), the direct subtype comparison surviving the reported phosphorus-family multiplicity criterion. Other direct energetic and PE/PDE subtype contrasts were nominal. A 42.5-percentage-point energetic-minus-membrane separation versus 10.3 points in PD-noRBD is an unadjusted group-level description. Regional-volume subtype differences were 0.4%-3.6% without significant omnibus effects. Published PE-related ratios correlated with RBD-HK severity; original internally evaluated classifier AUCs were 0.80 for phosphorus imaging and 0.86 for multimodal imaging. The summary-level reanalysis clarifies cross-domain effect magnitude, statistical hierarchy and inferential identifiability. Questionnaire-defined RBD, variable spectral sample sizes and internal-only ROC assessment limit translation. Cross-sectional results do not establish that metabolic changes temporally precede structural degeneration.
No takes yet. Share an insight, caveat, or question.
Aris Tsai (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: